User contributions for Dli29
Jump to navigation
Jump to search
7 February 2020
- 06:5806:58, 7 February 2020 diff hist +1,196 VITAL (Omega-3 arm) No edit summary
- 06:2806:28, 7 February 2020 diff hist +4,627 N GWPCARE4 Created page with "==Clinical Question== <!-- This should be a PICO (Population, Intervention, Comparison, Outcome) style question. As an example, the ACCORD trial's clinical question is shown b..." current
- 06:0106:01, 7 February 2020 diff hist +196 Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia No edit summary
- 05:3205:32, 7 February 2020 diff hist +101 VITAL (Omega-3 arm) No edit summary
6 February 2020
- 07:0407:04, 6 February 2020 diff hist +9 VITAL (Omega-3 arm) No edit summary
- 07:0307:03, 6 February 2020 diff hist +2 Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele No edit summary current
- 07:0307:03, 6 February 2020 diff hist +270 Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele →Further Reading
- 06:5606:56, 6 February 2020 diff hist +396 Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele No edit summary
- 06:4806:48, 6 February 2020 diff hist +301 Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele No edit summary
- 06:2406:24, 6 February 2020 diff hist +5,385 N Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele Created page with "Middleton PG, Mall MA, Drevinek P, et al. Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele. N Engl J Med. 2019;381:1809-19. ==Clinical Ques..."
- 06:0506:05, 6 February 2020 diff hist +140 VITAL (Omega-3 arm) No edit summary
- 06:0306:03, 6 February 2020 diff hist +917 VITAL (Omega-3 arm) No edit summary
- 04:5004:50, 6 February 2020 diff hist +140 VITAL (Omega-3 arm) No edit summary
- 04:3704:37, 6 February 2020 diff hist +5,061 N VITAL (Omega-3 arm) Created page with "==Clinical Question== <!-- This should be a PICO (Population, Intervention, Comparison, Outcome) style question. As an example, the ACCORD trial's clinical question is shown b..."
- 03:5803:58, 6 February 2020 diff hist −4 Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia No edit summary
- 03:5703:57, 6 February 2020 diff hist 0 Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia No edit summary
- 02:1002:10, 6 February 2020 diff hist +237 Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia No edit summary
- 01:5901:59, 6 February 2020 diff hist +153 Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia No edit summary
5 February 2020
- 05:1505:15, 5 February 2020 diff hist +1,246 Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia No edit summary
2 February 2020
- 23:2123:21, 2 February 2020 diff hist +397 Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia No edit summary
- 23:1623:16, 2 February 2020 diff hist −42 Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia No edit summary
28 January 2020
- 05:1005:10, 28 January 2020 diff hist +441 Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia No edit summary
- 04:2604:26, 28 January 2020 diff hist −223 Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia No edit summary
- 04:1504:15, 28 January 2020 diff hist +5,288 N Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia Created page with "==Clinical Question== <!-- This should be a PICO (Population, Intervention, Comparison, Outcome) style question. As an example, the ACCORD trial's clinical question is shown b..."